Michael B. Jordan, MD

Emapalumab Treatment in Patients With Rheumatologic Disease-Associated Hemophagocytic Lymphohistiocytosis in the United States: A Retrospective Medical Chart Review Study. Chandrakasan, S; Allen, CE; Bhatla, D; Carter, J; Chien, M; Cooper, R; Draper, L; Eckstein, OS; Hanna, R; Hays, JA; Hermiston, ML; Modica, R; Baker, A; Ward, B. Arthritis and Rheumatology. 2025; 77:226-238.

The role of C-reactive protein and ferritin in the diagnosis of HLH, adult-onset still's disease, and COVID-19 cytokine storm. Goubran, M; Spaner, C; Stukas, S; Zoref-Lorenz, A; Shojania, K; Beckett, M; Li, A; Peterson, E; Sekhon, M; Grey, R; Mattman, A; Jordan, MB; Chen, LY C; Setiadi, A. Scientific Reports. 2024; 14:31306.

Emapalumab therapy for hemophagocytic lymphohistiocytosis before reduced-intensity transplantation improves chimerism. Verkamp, B; Jodele, S; Sabulski, A; Marsh, R; Kieser, P; Jordan, MB. Blood. 2024; 144:2625-2636.

Diagnostic guidelines for familial hemophagocytic lymphohistiocytosis revisited. Henter, JI; Sieni, E; Eriksson, J; Bergsten, E; Hed Myrberg, I; Canna, SW; Coniglio, ML; Cron, RQ; Kernan, KF; Kumar, AR; Bottai, M; Bryceson, YT; Horne, AC; Jordan, MB. Blood. 2024; 144:2308-2318.

Insights into the Natural History and Treatment Outcomes of Hemophagocytic Lymphohistiocytosis (INTO-HLH) Patient Registry: Study Design and Clinical Characteristics. Zoref-Lorenz, A; Fajgenbaum, DC; Korn, S; Kaufmann, T; Anderson, B; Oladapo, A; Saltonstall, L; Fournier, D; Behrens, E; Allen, CE; Jordan, MB. Blood. 2024; 144:5389.

Assessment of the Optimized HLH Inflammatory (OHI) Index in a Prospective Cohort of Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma. Zoref-Lorenz, A; Cahn, EJ; Mou, E; Wang, Y; Maurer, MJ; Feldman, AL; Negaard, BJ; Mwangi, R; Itchaki, G; Nowakowski, GS; Goyal, G; Witzig, TE; Cerhan, JR; Jordan, MB. Blood. 2024; 144:1624.

Transplant Related Outcomes in Patients with Hemophagocytic Lymphohistiocytosis Treated with Emapalumab As a Bridge to Hematopoietic Stem Cell Transplantation: The Real-HLH Study. Allen, CE; Chandrakasan, S; Jordan, MB; Leiding, JW; Marrone, M; Oladapo, A; Pednekar, P; Walkovich, KJ; Yee, J. Blood. 2024; 144:3489.

Targeting PRMT5 in Primary Hemophagocytic Lymphohistiocytosis: A Novel Therapeutic Approach Using a Perforin-Deficient Mouse Model. Steyn, S; Chen, C; Saadey, R; Mao, C; Scherle, PA; Bhagwat, N; Vaddi, K; Brooks, E; Baiocchi, R; Jordan, MB; Shindiapina, P. Blood. 2024; 144:809.

Real-world treatment patterns and outcomes in patients with primary hemophagocytic lymphohistiocytosis treated with emapalumab. Chandrakasan, S; Jordan, MB; Baker, A; Behrens, EM; Bhatla, D; Chien, M; Eckstein, OS; Henry, MM; Hermiston, ML; Hinson, AP; Walkovich, KJ; Yee, JD; Zoref-Lorenz, A; Allen, CE. Blood Advances. 2024; 8:2248-2258.

COVID-19 Vaccination in Patients with Inborn Errors of Immunity Reduces Hospitalization and Critical Care Needs Related to COVID-19: a USIDNET Report. McDonnell, J; Cousins, K; Younger, ME M; Lane, A; Abolhassani, H; Abraham, RS; Al-Tamemi, S; Aldave-Becerra, JC; Al-Faris, EH; Alfaro-Murillo, A; Lim, XR; Lopes, JP; López, AL; Tarquini, L. Journal of Clinical Immunology. 2024; 44:86.